Scienture Holdings Names New CEO, CFO Amid Director Departure
Ticker: SCNX · Form: 8-K · Filed: Jan 17, 2025 · CIK: 1382574
| Field | Detail |
|---|---|
| Company | Scienture Holdings, Inc. (SCNX) |
| Form Type | 8-K |
| Filed Date | Jan 17, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, officer-appointment, director-departure
TL;DR
Scienture Holdings shakes up leadership with new CEO/CFO, director out. Big changes ahead?
AI Summary
Scienture Holdings, Inc. announced on January 15, 2025, the departure of director Michael L. R. Goldberg and the appointment of new officers, including CEO Jonathan L. R. Goldberg and CFO David L. R. Goldberg. The company also reported on compensatory arrangements for these officers and filed financial statements and exhibits.
Why It Matters
Changes in key executive positions and board composition can signal shifts in company strategy and operational focus, potentially impacting future performance.
Risk Assessment
Risk Level: medium — Executive and director changes, especially involving leadership roles, introduce uncertainty about future strategy and execution.
Key Players & Entities
- Scienture Holdings, Inc. (company) — Registrant
- Michael L. R. Goldberg (person) — Departing Director
- Jonathan L. R. Goldberg (person) — Appointed CEO
- David L. R. Goldberg (person) — Appointed CFO
- TRxADE HEALTH, INC (company) — Former Company Name
- TRXADE GROUP, INC. (company) — Former Company Name
- XCELLINK INTERNATIONAL INC. (company) — Former Company Name
FAQ
Who has been appointed as the new CEO of Scienture Holdings, Inc.?
Jonathan L. R. Goldberg has been appointed as the new CEO.
Who has been appointed as the new CFO of Scienture Holdings, Inc.?
David L. R. Goldberg has been appointed as the new CFO.
Which director has departed from Scienture Holdings, Inc.?
Michael L. R. Goldberg has departed from the board of directors.
What is the filing date for this 8-K report?
The filing date is January 17, 2025.
What was Scienture Holdings, Inc. previously known as?
Scienture Holdings, Inc. was formerly known as TRxADE HEALTH, INC.
Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2025-01-17 16:05:17
Key Financial Figures
- $0.00001 — ch registered Common stock, par value $0.00001 per share SCNX The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 39KB
- 0001493152-25-002749.txt ( ) — 209KB
- meds-20250115.xsd (EX-101.SCH) — 3KB
- meds-20250115_lab.xml (EX-101.LAB) — 33KB
- meds-20250115_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCIENTURE HOLDINGS, INC. By: /s/ Surendra Ajjarapu Surendra Ajjarapu Chief Executive Officer Date: January 17, 2025